This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Macrogenics, Inc.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Wei Chen: Innovator in Bi-specific Monovalent Fc Diabodies
Introduction
Wei Chen is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of bi-specific monovalent Fc diabodies, with a focus on their applications in treating inflammatory diseases.
Latest Patents
Wei Chen holds 2 patents. His latest patents include bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b. These inventions are directed towards compositions that contain these diabodies and methods for their use in treating conditions such as systemic lupus erythematosus (SLE) and graft vs. host disease.
Career Highlights
Wei Chen is currently employed at Macrogenics, Inc., where he continues to advance his research and development efforts in the field of immunology. His work has the potential to significantly impact therapeutic strategies for various inflammatory conditions.
Collaborations
Some of his notable coworkers include Leslie Sydnor Johnson and Ling Ling Huang. Their collaborative efforts contribute to the innovative research environment at Macrogenics, Inc.
Conclusion
Wei Chen's work in bi-specific monovalent Fc diabodies exemplifies the innovative spirit of modern science, aiming to provide new solutions for complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile